Well-differentiated papillary mesothelioma of the pleura: a series of 2 24 cases, Am J Surg Pathol, vol.28, pp.534-540, 2004. ,
Health effects of 4 exposure to carbon nanofibers: systematic review, critical appraisal, meta analysis and 5 research to practice perspectives, Sci Total Environ, vol.407, pp.3686-3701, 2009. ,
,
Identification of cancer stem 9 cell markers in human malignant mesothelioma cells, Biochem Biophys Res Commun, vol.10, pp.735-742, 2011. ,
,
Using gene expression ratios to 13 predict outcome among patients with mesothelioma, J Natl Cancer Inst, vol.95, pp.598-605, 2003. ,
,
Four-gene 16 expression ratio test for survival in patients undergoing surgery for mesothelioma, Cancer Inst, vol.17, pp.678-686, 2009. ,
, , p.19
Validation of genomics-based prognostic 20 tests in malignant pleural mesothelioma, Clin Cancer Res, vol.11, pp.4406-4414, 2005. ,
Domestic 23 asbestos exposure: a review of epidemiologic and exposure data, Int J Environ Res Public 24 Health, vol.10, pp.5629-5670, 2013. ,
, , p.26
, , p.27
28 Epigenetic profiles distinguish malignant pleural mesothelioma from lung 29 adenocarcinoma, Cancer Res, vol.69, pp.9073-9082, 2009. ,
Perspectives on refractory ceramic 31 fiber (RCF) carcinogenicity: comparisons with other fibers, Inhal Toxicol, vol.26, 2014. ,
, , p.34
, , 2014.
, Carcinogenicity of fluoro-edenite, silicon carbide fibres and whiskers, and carbon 36 nanotubes, Lancet Oncol, vol.15, pp.1427-1428
, , p.38
Whole exome sequencing reveals frequent genetic 39 alterations in BAP1, NF2, CDKN2A and CUL1 in malignant pleural mesothelioma, 2015. ,
, Cancer Res, vol.75, pp.264-269
,
,
Asbestos and erionite prime and activate the NLRP3 44 inflammasome that stimulates autocrine cytokine release in human mesothelial cells, vol.10, p.39, 2013. ,
Mesothelioma: cases associated with non-occupational and low dose 1 exposures, Occup Environ Med, vol.56, pp.505-513, 1999. ,
,
Gene expression profiling identifies matriptase overexpression in 4 malignant mesothelioma, Chest, vol.125, pp.1843-1852, 2004. ,
,
A molecular diagnostic test for distinguishing lung adenocarcinoma from 7 malignant mesothelioma using cells collected from pleural effusions, Clin Cancer Res, vol.8, pp.5129-5135, 2006. ,
,
,
,
Guidelines for Pathologic Diagnosis of Malignant 13 Mesothelioma: 2012 Update of the Consensus Statement from the International 14, 2013. ,
, Mesothelioma Interest Group. Arch Pathol Lab Med, vol.137, pp.647-667
,
Utility of BAP1 Immunohistochemistry and p16 (CDKN2A) FISH in the 18 Diagnosis of Malignant Mesothelioma in Effusion Cytology Specimens, Am J Surg 19 Pathol, vol.40, pp.120-126, 2015. ,
, IARC Monograph on the valuation of 21 carcinogenic risks to humans, vol.81, 2002.
, C IARC 23 Monographs on the Evaluation of Carcinogenic Risks to Humans, IARC. 2012. Arsenic, metals, fibres, and dusts. A review of human carcinogens, vol.100
Mesothelioma not associated with asbestos exposure, Arch Pathol, vol.25, pp.262-267, 2012. ,
Health effects of carbon nanotubes and some comparisons with natural 27 mineral nanotubes, Natural mineral nanotubes. Properties and applications, p.29, 2015. ,
In press. Safety of tubular clay minerals: an overview, Nanosized Tubular Clay 31 Minerals ,
, Biomolecular Pathways and Malignant Pleural Mesothelioma, 2016.
URL : https://hal.archives-ouvertes.fr/inserm-02479956
, Malignant Pleural Mesothelioma: Present Status and Future Directions
,
36 Molecular changes in mesothelioma with an impact on prognosis and treatment, Arch 37 Pathol Lab Med, vol.136, pp.277-293, 2012. ,
, , p.39
Syntenic 40 relationships between genomic profiles of fiber-induced murine and human malignant 41 mesothelioma, Am J Pathol, vol.176, pp.881-894, 2011. ,
43 Asbestos: use, bans and disease burden in Europe, Bull World Health Organ, vol.92, pp.790-797, 2014. ,
Mesothelioma from chrysotile asbestos: update, Ann Epidemiol, vol.21, pp.688-734, 2011. ,
,
Whole exome and targeted deep 2 sequencing identify genome-wide allelic loss and frequent SETDB1 mutations in 3 malignant pleural mesotheliomas, Oncotarget, 2016. ,
,
,
A Significant Metabolic and Radiological Response after a Novel 7 Targeted MicroRNA-based Treatment Approach in Malignant Pleural Mesothelioma, Am 8 J Respir Crit Care Med, vol.191, pp.1467-1469, 2015. ,
Pulmonary toxicity of carbon 10 nanotubes: a systematic report, Nanomedicine, vol.7, pp.40-49, 2011. ,
, , p.12
MiR-score: a novel 6-microRNA 13 signature that predicts survival outcomes in patients with malignant pleural mesothelioma, 2015. ,
, Mol Oncol, vol.9, pp.715-726
, , p.16
Integrated high-resolution array CGH and SKY analysis 17 of homozygous deletions and other genomic alterations present in malignant 18 mesothelioma cell lines, Cancer Genet, vol.206, pp.191-205, 2013. ,
Early and delayed effects of naturally occurring asbestos on serum biomarkers of 22 inflammation and metabolism, J Toxicol Environ Health A, vol.21, pp.1024-1039, 2014. ,
Mapping the risk of mesothelioma due to neighborhood 25 asbestos exposure, Am J Respir Crit Care Med, vol.178, pp.624-629, 2008. ,
, , p.28
Pleural mesothelioma and occupational coexposure to 29 asbestos, mineral wool, and silica, Am J Respir Crit Care Med, vol.187, pp.977-982, 2013. ,
Co-exposure to refractory ceramic fibres and asbestos and risk of 33 pleural mesothelioma, Eur Respir J, vol.44, pp.725-733, 2014. ,
,
Occupational asbestos exposure is associated with 36 pharyngeal squamous cell carcinoma in men from the greater Boston area, Occup Environ 37 Med, vol.70, pp.858-863, 2013. ,
Some further industrial, environmental and biomedical applications of 39 halloysite nanotubes, Natural mineral nanotubes. Properties and applications, 2015. ,
Esophagus cancer and occupational exposure to 43 asbestos: results from a meta-analysis of epidemiology studies, 2015. ,
, , p.46
Mutational analysis of hedgehog signaling 47 pathway genes in human malignant mesothelioma, PLoS ONE, vol.8, 2013. ,
Toxicological and epidemiological studies on effects of airborne fibers: 3 coherence and public [corrected] health implications, Crit Rev Toxicol, vol.44, pp.643-695, 2014. ,
,
Targeted next-generation 7 sequencing of cancer genes in advanced stage malignant pleural mesothelioma: a 8 retrospective study, J Thorac Oncol, vol.10, pp.492-499, 2015. ,
A 10 longitudinal study of chest radiographic changes of workers in the refractory ceramic 11 fiber industry, Chest, vol.121, pp.2044-2051, 2002. ,
13 Refractory ceramic fiber exposure and pleural plaques, Am J Respir Crit Care Med, vol.14, pp.1405-1410, 1996. ,
,
Global gene 17 expression profiling of pleural mesotheliomas: overexpression of aurora kinases and 18 P16/CDKN2A deletion as prognostic factors and critical evaluation of microarray-based 19 prognostic prediction, Cancer Res, vol.66, pp.2970-2979, 2006. ,
21 Toxicological evaluation of clay minerals and derived nanocomposites: a review, Environ 22 Res, vol.138, pp.233-254, 2015. ,
Upregulation 24 of microRNA-31 associates with a poor prognosis of malignant pleural mesothelioma 25 with sarcomatoid component, Med Oncol, vol.31, p.303, 2014. ,
Comparative Genomic Hybridization Studies on Mesothelioma Show a Parallel 28 Fate of 1p21-1p22 and 9p21 Bands and a Chromosomally Stable Sub-Group, American 29 Journal of Medical and Biological Research, vol.27, pp.149-158, 2013. ,
, , p.31
A review of transcriptome studies 32 combined with data mining reveals novel potential markers of malignant pleural 33 mesothelioma, Mutat Res, vol.750, pp.132-140, 2012. ,
, , p.35
, , p.36
Expression status of candidate genes in mesothelioma 37 tissues and cell lines, Mutat Res, vol.771, pp.6-12, 2015. ,
,
The joint effect of asbestos 40 exposure, tobacco smoking and alcohol drinking on laryngeal cancer risk: evidence from 41 the French population-based case-control study, ICARE, Occup Environ Med, vol.73, 2016. ,
, , p.44
Mutation analysis of the EGFR 45 gene and downstream signalling pathway in histologic samples of malignant pleural 46 mesothelioma, Br J Cancer, vol.108, pp.1743-1749, 2013. ,
,
Hippo pathway gene mutations in malignant 2 mesothelioma: revealed by RNA and targeted exon sequencing, J Thorac Oncol, vol.10, pp.844-847, 2015. ,
, , p.5
LATS2 Is a Tumor 6 Suppressor Gene of Malignant Mesothelioma, Cancer Res, vol.71, pp.873-883, 2011. ,
Tumours associated with BAP1 mutations, vol.9, pp.116-126, 2013. ,
,
Predicting survival in malignant 12 mesothelioma, Eur Respir J, vol.38, pp.1420-1424, 2011. ,
,
,
High Incidence of Somatic BAP1 alterations in sporadic 16 malignant mesothelioma, J Thorac Oncol, vol.10, pp.565-576, 2015. ,
Asbestos fibers and other elongate mineral particles: State of the science and 19 roadmap for research, Current Intelligence Bulletin, vol.62, pp.1-153, 2011. ,
Occupational asbestos exposure and risk of pleural 22 mesothelioma, lung cancer, and laryngeal cancer in the prospective Netherlands cohort 23 study, J Occup Environ Med, vol.56, pp.6-19, 2014. ,
, , p.25
Occupational asbestos 26 exposure and risk of esophageal, gastric and colorectal cancer in the prospective 27 Netherlands Cohort Study, Int J Cancer, vol.135, pp.1970-1977, 2014. ,
29 High incidence of lung cancer and malignant mesothelioma linked to erionite fibre 30 exposure in a rural community in Central Mexico, Occup Environ Med, vol.72, pp.216-218, 2015. ,
, , p.33
Asbestos exposure, 34 pleural plaques, and the risk of death from lung cancer, Am J Respir Crit Care Med, vol.35, pp.1413-1420, 2014. ,
, , p.37
,
Pleural plaques and the risk of pleural mesothelioma, Cancer Inst, vol.39, pp.293-301, 2013. ,
RNA sequencing identifies fusion of the EWSR1 and YY1 genes in mesothelioma, vol.41, 2013. ,
, Genes Chromosomes Cancer, vol.52, pp.733-740
45 The established and future biomarkers of malignant pleural mesothelioma, Cancer Treat, vol.46, pp.486-495, 2015. ,
, , p.1
,
Characterisation of 3 mesothelioma-initiating cells and their susceptibility to anti-cancer agents, PLoS ONE, vol.4, 2015. ,
, , p.6
hsa-miR-29c* Is Linked to 7 the Prognosis of Malignant Pleural Mesothelioma, Cancer Res, vol.70, pp.1916-1924, 2010. ,
Gene expression profiles predict survival and progression of pleural 10 mesothelioma, Clin Cancer Res, vol.10, pp.849-859, 2004. ,
, , p.12, 2014.
, Predictive role of repair enzymes in the efficacy of Cisplatin combinations in pancreatic 13 and lung cancer, Anticancer Res, vol.34, pp.435-442
Role of Merlin/NF2 inactivation in tumor biology, 15 Oncogene, vol.35, pp.537-548, 2015. ,
Risk of 17 mesothelioma and occupational exposure to asbestos and man-made vitreous fibers: 18 evidence from two case-control studies in Montreal, Canada, J Occup Environ Med, vol.19, pp.1177-1184, 2009. ,
Secreted frizzled-related 21 protein 4 and its implications in cancer and apoptosis, Tumour Biol, vol.36, pp.143-152, 2015. ,
Cancer incidence among firefighters: 45 years of follow-up in 25 five Nordic countries, Occup Environ Med, vol.71, pp.398-404, 2014. ,
Occupational, 28 domestic and environmental mesothelioma risks in the British population: a case-control 29 study, Br J Cancer, vol.100, pp.1175-1183, 2009. ,
, , p.31
Detection of pleural plaques in workers exposed to 32 inhalation of natural fluoro-edenite fibres, Oncol Lett, vol.9, pp.2046-2052, 2015. ,
,
All-cause mortality and cancer incidence among adults exposed to blue 36 asbestos during childhood, Am J Ind Med, vol.56, pp.133-145, 2013. ,
MicroRNAs in mesothelioma: from tumour suppressors and biomarkers to 38 therapeutic targets, J Thorac Dis, vol.7, pp.1031-1040, 2015. ,
Malignant mesothelioma, Lancet, vol.366, pp.397-438, 2005. ,
Asbestos 43 and man-made vitreous fibers as risk factors for diffuse malignant mesothelioma: results 44 from a German hospital-based case-control study, Am J Ind Med, vol.39, pp.262-275, 2001. ,
,
,
Occupations and industries in France at high risk for pleural 1 mesothelioma: A population-based case-control study (1998-2002), Am J Ind Med, vol.2, pp.1207-1219, 2010. ,
4 Prevalence of BRCA-1 associated protein 1 germline mutation in sporadic malignant 5 pleural mesothelioma cases, Lung Cancer, vol.87, pp.77-79, 2015. ,
,
,
Guidelines of 9 the European Respiratory Society and the European Society of Thoracic Surgeons for the 10 management of malignant pleural mesothelioma, Eur Respir J, vol.35, pp.479-495, 2010. ,
Low frequency of EGFR mutations in pleural mesothelioma 13 patients, Appl Immunohistochem Mol Morphol, vol.23, pp.118-125, 2015. ,
, , p.16, 1975.
, Topographic distribution of asbestos fibres in human lung in relation to occupational and 17 non-occupational exposure, Inhaled Part, vol.4, pp.435-446
Genomic abnormalities and signal transduction dysregulation in malignant 19 mesothelioma cells, Cancer Sci, vol.101, pp.1-6, 2010. ,
Molecular pathogenesis of malignant mesothelioma, Carcinogenesis, vol.34, pp.1413-1434, 2013. ,
Asbestos exposure and neoplasia, Jama, vol.23, pp.22-26, 1964. ,
, , p.25
,
Identification of actionable mutations in 27 malignant pleural mesothelioma, Lung Cancer, vol.86, 2014. ,
Mechanisms of pulmonary toxicity and medical applications of carbon nanotubes: 31 Two faces of Janus?, Pharmacol Ther, vol.121, pp.192-204, 2009. ,
, , p.33
Integrated Analysis of Dysregulated ncRNA and mRNA Expression 34 Profiles in Humans Exposed to Carbon Nanotubes, PLoS One, vol.11, 2016. ,
Pulmonary asbestosis in South Africa, Br Med J, vol.1, issue.3516, pp.885-887, 1928. ,
Malignant mesothelioma: attributable risk of asbestos exposure, Environ Med, vol.40, pp.804-811, 1994. ,
The worldwide pandemic of asbestos-related 42 diseases, Annu Rev Public Health, vol.34, pp.205-216, 2013. ,
, , p.45
,
Expression profiling 47 stratifies mesothelioma tumors and signifies deregulation of spindle checkpoint pathway 1 and microtubule network with therapeutic implications, Ann Oncol, vol.25, pp.1184-1192, 2014. ,
, , p.4
5 Overexpression and promoter mutation of the TERT gene in malignant pleural 6 mesothelioma, Oncogene, vol.33, pp.3748-3452, 2014. ,
, , vol.8
Pleural 9 mesothelioma in relation to meteorological conditions and residential distance from an 10 industrial source of asbestos, Occup Environ Med, vol.70, pp.588-590, 2013. ,
,
, , p.14
Germline BAP1 mutations predispose to 15 malignant mesothelioma, Nat Genet, vol.43, pp.1022-1025, 2011. ,
, , p.17
Expression of the Stem Cell Factor Nestin in 18 Malignant Pleural Mesothelioma Is Associated with Poor Prognosis, PLoS ONE, vol.19, 2015. ,
21 Functional inactivation of NF2/merlin in human mesothelioma, Lung Cancer, vol.64, pp.140-147, 2009. ,
DNA repair systems in malignant mesothelioma, 2011. ,
, Cancer Lett, vol.312, pp.143-149
,
A hypothetical model for predicting the toxicity of high aspect ratio 27 nanoparticles (HARN), J Nanopart Res, vol.13, pp.6683-6698, 2011. ,
Carbon nanofibers and carbon nanotubes in 29 regenerative medicine, Adv Drug Deliv Rev, vol.61, 2009. ,
,
,
Preclinical evaluation of microRNA-34b/c delivery for malignant pleural 34 mesothelioma, Acta Med Okayama, vol.68, pp.23-26, 2014. ,
Application of carbon 36 nanotube technology for removal of contaminants in drinking water: a review, Sci Total 37 Environ, vol.408, pp.1-13, 2009. ,
Applications of natural mineral nanotubes in nanocomposites, 2015. ,
, Natural mineral nanotubes. Properties and applications, p.41
, , p.43
Lung cancer risk at low cumulative asbestos exposure: meta-regression 44 of the exposure-response relationship, Cancer Causes Control, vol.24, 2013. ,
The role of epigenetics in malignant pleural mesothelioma, Lung Cancer, vol.1, pp.311-313, 2013. ,
Diffuse pleural mesothelioma and asbestos 4 exposure in the North Western Cape Province, Br J Ind Med, vol.17, pp.260-271, 1960. ,
Codeletion of 6 p15 and p16 in primary malignant mesothelioma, Oncogene, vol.11, pp.511-515, 1995. ,
,
Germline mutation 9 of Bap1 accelerates development of asbestos-induced malignant mesothelioma, Cancer 10 Res, vol.74, pp.4388-4397, 2014. ,
,
Frequent inactivation of the BAP1 gene in epithelioid-14 type malignant mesothelioma, Cancer Sci, vol.103, pp.868-874, 2012. ,
,
, , p.18
Bevacizumab for newly diagnosed 20 pleural mesothelioma in the Mesothelioma Avastin Cisplatin Pemetrexed Study (MAPS): 21 a randomised, controlled, open-label, pp.1238-1244, 2015. ,
Clinical characteristics of patients with malignant pleural mesothelioma harboring 25 somatic BAP1 mutations, J Thorac Oncol, vol.24, pp.1430-1433, 2013. ,